CELLnTEC

CnT-Prime Epithelial Proliferation Medium, EGF/FGF-Free

Product Code:
 
CnT-PR-EF
Supplier:
 
CELLnTEC
Regulatory Status:
 
RUO
Target Species:
  • Human
  • Mouse
Shipping:
 
Dry ice
Storage:
 
Below -15°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
CnT-PR-EF500 mL (frozen)£260.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Related Products
  • Show All

Further Information

Animal and Human Component-Free?:
Yes
Application:
Differentiation
Chemically Defined?:
Yes
Clinically Upgradable?:
Yes
Component(s):
Frozen Bottle & Ready-to-use
Contains Bovine Pituitary Extract (BPE)?:
No
Contains Serum?:
No
Description:
CnT-PR-EF is a chemically defined, animal component free medium for differentiation of human iPSC and ESC down corneal lineages. This medium contains low growth factors and is free of EGF and EGF to deliver the desired differentiation of iPS cells.
Quality Level:
Research Grade
Species to be used on:
Human & Mouse
Tissue Type:
IPSC

References

  • Toru Okubo, 2020. Generation and validation of a PITX2?EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells . Journal: Journal of Biological Chemistry. Authors: Toru Okubo, Ryuhei Hayashi, Shun Shibata, Yuji Kudo, Yuki Ishikawa, Saki Inoue, Yuki Kobayashi, Ai Honda, Yoichi Honma, Satoshi Kawasaki, Kohji Nishida . Osaka, Japan.
  • Yuki Kobayashi, 2020. Ocular Surface Ectoderm Instigated by WNT inhibition and BMP4. Journal: Stem Cell Research. Authors: Yuki Kobayashi, Ryuhei Hayashi, Shun Shibata, Andrew J. Quantock, Kohji Nishida. Osaka, Japan.
  • Shinya Watanabe, 2021. Human iPS cells engender corneal epithelial stem cells with holoclone-forming capabilities. Journal: iScience. Authors: Shinya Watanabe, Ryuhei Hayashi, Yuzuru Sasamoto, Motokazu Tsujikawa, Bruce R. Ksander, Markus H. Frank, Andrew J. Quantock, Natasha Y. Frank, Kohji Nishida. Osaka, Japan.
  • Ryuhei Hayashi, 2022. Generation of 3D lacrimal gland organoids from human pluripotent stem cells. Journal: Nature. Authors: Ryuhei Hayashi, Toru Okubo, Yuji Kudo, Yuki Ishikawa, Tsutomu Imaizumi, Kenji Suzuki, Shun Shibata, Tomohiko Katayama, Sung-Joon Park, Robert D. Young, Andrew J. Quantock, Kohji Nishida . Osaka, Japan.
  • Masahiro Kitao, 2023. Identification of BST2 as a conjunctival epithelial stem/progenitor cell marker. Journal: iScience. Authors: Masahiro Kitao, Ryuhei Hayashi, Kimihito Nomi, Reiko Kobayashi, Tomohiko Katayama, Hiroshi Takayanagi, Akiko Oguchi, Yasuhiro Murakawa, Kohji Nishida. Osaka, Japan.